Management of Myoma

Authors

  • Fatahillah Fatahillah Universitas Lampung
  • Rizki Hanriko
  • Linda Septiani
  • Ratna Dewi Puspita Sari

DOI:

https://doi.org/10.53089/medula.v14i3.996

Keywords:

diagnostic, examination, managemnet, myoma

Abstract

Myoma or uterine fibroids are benign tumors that often occur in the uterine wall. Myomas can be asymptomatic or cause symptoms such as abnormal bleeding, pelvic pain, and disorders of the urinary tract. Risk factors include age, race, age of menarche, parity, family history, hormonal contraceptive use, and obesity. Diagnostic examination involves pelvic examination, ultrasound, hysteroscopy, and MRI. Medical therapies used such as NSAIDs, oral contraceptives, Levonorgestrel-releasing intrauterine system (Mirena), tranexamic acid (cyclocapron), GnRH agonists and SPRMs and surgeries such as myomectomy, hysterectomy, uterine artery embolization, and MRgFUS. Management of Myoma must consider various factors, namely tumor size, patient age, symptom and the desire to maintain fertility in order to provide optimal treatment according to the patient's needs and preferences.

Author Biographies

Fatahillah Fatahillah, Universitas Lampung

 

 

Rizki Hanriko

 

 

Linda Septiani

 

 

Ratna Dewi Puspita Sari

 

 

References

Saifuddin AB, Rachimhadhi T, Wiknjosastro GH. Ilmu kebidanan Sarwono Prawirohardjo. Jakarta : PT. Bina Pustaka Sarwono Prawirohardjo; 2016.

Donnez J, Dolmans MM. Uterine Fibroid Management: From The Present To The Future. Hum Reprod Update. 2016;22(6):665-686.

Global Health Data Exchange. Uterine fibroids prevalence; 2019.

WHO. Maternal Mortality. World Health Organization; 2014.

Ningrum NW, Rahman RTA, Mahmudah. Hubungan Obesitas Dan Riwayat Keluarga Dengan Kejadian Mioma Uteri Di Ruang Poli Kandungan Rsud Dr. H. Moch Ansori Saleh Banjarmasin Tahun 2016. Dinamika Kesehatan. 2018;9(1): 594-606.

Meilani NS, Mansoer FAF, Nur IM, Argadireja DS, Widjajanegara H. Hubungan Usia Dan Paritas Dengan Kejadian Mioma Uteri di RSUD Al-Ihsan Provinsi Jawa Barat Tahun 2017. Jurnal Integrasi Kesehatan & Sains (JIKS). 2020;2(1):18–21.

Dinas Kesehatan Provinsi Lampung. Profil Kesehatan Lampung Tahun 2013. Bandar Lampung; 2013.

Reis FM, Bloise E, Ortiga-Carvalho TM. Hormones And Pathogenesis Of Uterine Fibroids. Best Practice And Research: Clinical Obstetrics And Gynaecology. 2016;34(1): 13–24.

Valle RF, Ekpo GE. Pathophysiology Of Myomas And Its Clinical Implications. New York: Springer; 2015.

Stewart EA, Laughlin-Tommaso SK, Catherino WH, Lalitkumar S, Gupta D, Vollenhoven B. Uterine Fibroids. Nature Reviews Disease Primers. 2016;2(1): 1-18.

Williams ARW. Uterine Fibroids-What’s New?. F1000Research. 2017;6(1): 1-7.

Barjon K, Mikhail LN. Uterine Leiomyomata. In Statpearls. Treasure Island (FL): Statpearls Publishing; 2023.

Soliman AM, Margolis MK, Castelli-Haley J, Fuldeore MJ, Owens CD, Coyne KS. Impact Of Uterine Fibroid Symptoms On Health-Related Quality Of Life Of Us Women: Evidence From A Cross-Sectional Survey. Current Medical Research And Opinion. 2017;33(11): 1971–1978.

Ciavattini A, et al. Uterine Fibroids: Pathogenesis And Interactions With Endometrium And Endomyometrial Junction. Obstetrics And Gynecology International; 2013.

Rajuddin R, Donny D. Kehamilan Dengan Mioma Uteri Post Miomektomi. Averrous: Jurnal Kedokteran dan Kesehatan Malikussaleh. 2018;4(1).

Hartati S, Nirmala N, Winarti R. Asuhan Keperawatan Post Operasi Miomektomi Atas Indikasi Mioma Uteri Dengan Pendekatan Model Konsep Comfort Kolkaba Di Rumah Sakit. Nursing News : Jurnal Ilmiah Keperawatan. 2022;6(3): 133-143.

Jariah A, Abeng AT, Erawati M. Manajemen Asuhan Kebidanan pada Nona R dengan Mioma Uteri. Window of Midwifery Journal. 2020;1(2): 46-55.

Indrayana SF. Faktor – Faktor Yang Memengaruhi Kejadian Mioma Uteri Di Rumah Sakit Islam Sultan Agung Semarang. Undergraduate Thesis, Universitas Islam Sultan Agung; 2020.

Donnez J, Dolmans MM. Uterine Fibroid Management: From The Present To The Future. Hum Reprod Update. 2016;22(6):665-686.

Vilos GA, Allaire C, Laberge PY, dkk. Penatalaksanaan leiomioma uterus. J Obstet Gynaecol Bisa. 2015;37(2):157-181

Lethaby A, Duckitt K, Farquhar C. Obat antiinflamasi nonsteroid untuk perdarahan menstruasi berat.Sistem Basis Data Cochrane Rev. 2013; (1):CD000400

Lukes AS, Moore KA, Muse KN, dkk. Pengobatan asam traneksamat untuk pendarahan menstruasi yang berat.Obstet Ginekol. 2010;116(4):865-875.

Sayed GH, Zakherah MS, El-Nashar SA, dkk. Sebuah uji klinis acak dari sistem Steril Subur. 2009;91(1):240-243. intrauterin yang melepaskan levonorgestrel dan kontrasepsi oral kombinasi dosis rendah untuk menorrhagia terkait fibroid.Obstet Gynaecol Int J. 2011;112(2):126-130.

Donnez J, Tatarchuk TF, Bouchard P, dkk. Ulipristal asetat versus plasebo untuk pengobatan fibroid sebelum operasi.N Engl J Med. 2012;366(5):409-420.

Tristan M, Orozco LJ, Steed A, dkk. Mifepristone untuk fibroid rahim. Sistem Basis Data Cochrane Rev. 2012;(8):CD007687.

Sesti F, Cosi V, Calonzi F, dkk. Perbandingan acak histerektomi vagina dan vagina dengan laparoskopi total, bantuan laparoskopi, dan histerektomi vagina untuk rahim miomatosa.Obstet Ginekol Lengkungan. 2014;290(3):485-491.

Aarts JW, Nieboer TE, Johnson N, dkk. Pendekatan bedah histerektomi untuk penyakit ginekologi jinak.Sistem Basis Data Cochrane Rev. 2015; (8):CD003677.

Singh SS, Belland L. Penatalaksanaan kontemporer fibroid uterus: fokus pada perawatan medis yang muncul [koreksi yang dipublikasikan muncul diOpini Saat Ini Med Res. 2016;32(4):797].Opini Saat Ini Med Res. 2015;31(1):1-12.

Camanni M, Bonino L, Delpiano EM, dkk. Penatalaksanaan histeroskopi mioma uterus submukosa bergejala besar.J Minim Ginekol Invasif. 2010;17(1):59-65.

Bhave Chittawar P, Franik S, dkk. Teknik bedah invasif minimal versus miomektomi terbuka untuk fibroid rahim.Sistem Basis Data Cochrane Rev. 2014;(10):CD004638.

Gupta JK, Sinha A, Lumsden MA, dkk. Embolisasi arteri uterina untuk fibroid uterus yang bergejala.Sistem Basis Data Cochrane Rev. 2014; (12):CD005073.

Rabinovici J, David M, Fukunishi H, dkk.; Kelompok Studi MRgFUS. Hasil kehamilan setelah operasi ultrasonografi terfokus yang dipandu resonansi magnetik (MRgFUS) untuk pengobatan konservatif fibroid rahim.Steril Subur. 2010;93(1):199-209

Taran FA, Tempany CM, Regan L, dkk.; Grup MRgFUS. Ultrasonografi terfokus yang dipandu resonansi magnetik (MRgFUS) dibandingkan dengan histerektomi perut untuk pengobatan leiomioma uterus.USG Obstet Ginekol. 2009;34(5):572-578.

Published

2024-02-13

How to Cite

Fatahillah, F., Hanriko, R., Septiani, L., & Sari, R. D. P. (2024). Management of Myoma. Medical Profession Journal of Lampung, 14(3), 458-463. https://doi.org/10.53089/medula.v14i3.996

Issue

Section

Artikel

Most read articles by the same author(s)